{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:25:37Z","timestamp":1793190337101,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctoral School of Medicine and Pharmacy of \u201cVictor Babes\u201d University of Medicine and Pharmacy, Timisoara, Romania"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45656-1","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:45:50Z","timestamp":1774975550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular risk factor target control in Romanian adults with type 2 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Silvia Ana","family":"Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca Malina","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Herascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad Florian","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Timar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"15","key":"45656_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani, A. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N. Engl. J. Med. 376(15), 1407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1608664 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"2_suppl","key":"45656_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto, E. et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur. J. Prev. Cardiol. 26(2_suppl), 25\u201332. https:\/\/doi.org\/10.1177\/2047487319878371 (2019).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"45656_CR3","doi-asserted-by":"publisher","first-page":"e0299035","DOI":"10.1371\/journal.pone.0299035","volume":"19","author":"DK Song","year":"2024","unstructured":"Song, D. K., Hong, Y. S., Sung, Y. A. & Lee, H. Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus. PLoS One 19(2), e0299035. https:\/\/doi.org\/10.1371\/journal.pone.0299035 (2024).","journal-title":"PLoS One"},{"key":"45656_CR4","doi-asserted-by":"crossref","unstructured":"Rodriguez-Araujo G, Nakagami H. Pathophysiology of cardiovascular disease in diabetes mellitus. Cardiovasc Endocrinol Metab 7(1):4 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6739883\/ (2018).","DOI":"10.1097\/XCE.0000000000000141"},{"key":"45656_CR5","doi-asserted-by":"crossref","unstructured":"Katsiki N, Banach M, Mikhailidis DP. Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient! Archives of Medical Science 15(6):1357\u201364 https:\/\/www.archivesofmedicalscience.com\/Is-type-2-diabetes-mellitus-a-coronary-heart-disease-equivalent-or-not-Do-not-just,112409,0,2.html (2019)","DOI":"10.5114\/aoms.2019.89449"},{"key":"45656_CR6","doi-asserted-by":"crossref","unstructured":"Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, Lopez-Jimenez F. Cardiovascular diseases in central and eastern europe: a call for more surveillance and evidence-based health promotion. ann glob health 86(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/32166066\/ (2020).","DOI":"10.5334\/aogh.2713"},{"issue":"18","key":"45656_CR7","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1093\/eurjpc\/zwaa073","volume":"28","author":"AM Cebri\u00e1n-Cuenca","year":"2022","unstructured":"Cebri\u00e1n-Cuenca, A. M. et al. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC\/EASD: data from a large Mediterranean population. Eur. J. Prev. Cardiol. 28(18), e32-4. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa073 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"6","key":"45656_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P G\u00e6de","year":"2008","unstructured":"G\u00e6de, P., Lund-Andersen, H., Parving, H. H. & Pedersen, O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 358(6), 580\u201391. https:\/\/doi.org\/10.1056\/NEJMoa0706245 (2008).","journal-title":"N. Engl. J. Med."},{"key":"45656_CR9","doi-asserted-by":"crossref","unstructured":"Ryd\u00e9n L, Ferrannini G, Mellbin L. Risk factor reduction in type 2 diabetes demands a multifactorial approach. Eur J Prev Cardiol 26(2_suppl):81\u201391 https:\/\/pubmed.ncbi.nlm.nih.gov\/31766912\/ (2019).","DOI":"10.1177\/2047487319872015"},{"issue":"6","key":"45656_CR10","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/dom.15018","volume":"25","author":"SC Tye","year":"2023","unstructured":"Tye, S. C. et al. The importance of targeting multiple risk markers in patients with type 2 diabetes: a post-hoc study from the CANVAS programme. Diabetes Obes. Metab. 25(6), 1638\u201345. https:\/\/doi.org\/10.1111\/dom.15018 (2023).","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"45656_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani, A. et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 379(7), 633\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1800256 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"45656_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/ehjqcco\/qcae105","volume":"11","author":"N Marx","year":"2025","unstructured":"Marx, N. et al. Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings. Eur. Heart J. Qual. Care Clin. Outcomes 11(6), 868\u201374. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae105 (2025).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"39","key":"45656_CR13","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx, N. et al. ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur. Heart J. 44(39), 4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192 (2023).","journal-title":"Eur. Heart J."},{"key":"45656_CR14","doi-asserted-by":"crossref","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nature Reviews Cardiology 2023 20:10 20(10):685\u201395. https:\/\/www.nature.com\/articles\/s41569-023-00877-z (2023).","DOI":"10.1038\/s41569-023-00877-z"},{"issue":"20","key":"45656_CR15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/CIRCULATIONAHA.120.046783","volume":"142","author":"AK Wright","year":"2020","unstructured":"Wright, A. K. et al. Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings. Circulation 142(20), 1925\u201336 (2020).","journal-title":"Circulation"},{"issue":"10","key":"45656_CR16","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2337\/dc24-0864","volume":"47","author":"ZG Huang","year":"2024","unstructured":"Huang, Z. G. et al. Comprehensive multiple risk factor control in Type 2 Diabetes to mitigate heart failure risk: Insights from a prospective cohort study. Diabetes Care 47(10), 1818\u201325. https:\/\/doi.org\/10.2337\/dc24-0864 (2024).","journal-title":"Diabetes Care"},{"issue":"28","key":"45656_CR17","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","volume":"44","author":"L Pennells","year":"2023","unstructured":"Pennells, L. et al. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur. Heart J. 44(28), 2544\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehad260 (2023).","journal-title":"Eur. Heart J."},{"key":"45656_CR18","doi-asserted-by":"crossref","unstructured":"Reurean-Pintilei D, Potcovaru CG, Salmen T, Mititelu-Tartau L, Cintez\u0103 D, Laz\u0103r S, et al. Assessment of Cardiovascular Risk Categories and Achievement of Therapeutic Targets in European Patients with Type 2 diabetes. Journal of Clinical Medicine 13(8):2196 https:\/\/www.mdpi.com\/2077-0383\/13\/8\/2196\/htm (2024).","DOI":"10.3390\/jcm13082196"},{"key":"45656_CR19","doi-asserted-by":"crossref","unstructured":"Salmen T, Pietrosel VA, Reurean-Pintilei D, Iancu MA, Cimpeanu RC, Bica IC, et al. Assessing cardiovascular target attainment in type 2 diabetes mellitus patients in tertiary diabetes center in romania. Pharmaceuticals 17(9):1249 https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1249\/htm (2024).","DOI":"10.3390\/ph17091249"},{"key":"45656_CR20","doi-asserted-by":"crossref","unstructured":"Salem AM, Harris D, Bray JJH, Obaid DR, Stephens JW, Halcox J. Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis. Int J Cardiol 377:104\u201311. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0167527323001791?casa_token=04bEaAcBuUwAAAAA:RZy0OPYHAnQpU-zpgUErpCrXK27AlFXubYLQ0B19Cgg_wzaSubUUM_di3GajPeanc1AmclahUToj (2023)","DOI":"10.1016\/j.ijcard.2023.02.004"},{"key":"45656_CR21","doi-asserted-by":"crossref","unstructured":"Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, et al. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. The Lancet Regional Health - Europe 29:100624. https:\/\/www.thelancet.com\/action\/showFullText?pii=S2666776223000431 (2023)","DOI":"10.1016\/j.lanepe.2023.100624"},{"issue":"1","key":"45656_CR22","doi-asserted-by":"publisher","first-page":"E007480","DOI":"10.1161\/CIRCOUTCOMES.120.007480","volume":"14","author":"J Moon","year":"2021","unstructured":"Moon, J., Sedgh, R. C. & Jackevicius, C. A. Examining the nocebo effect of statins through statin adverse events reported in the food and drug administration adverse event reporting system. Circ. Cardiovasc. Qual. Outcomes 14(1), E007480. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.120.007480 (2021).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"45656_CR23","doi-asserted-by":"crossref","unstructured":"Andary R, Fan W, Wong ND. Control of cardiovascular risk factors among us adults with type 2 diabetes with and without cardiovascular disease. American Journal of Cardiology 124(4):522\u20137. https:\/\/www.ajconline.org\/action\/showFullText?pii=S0002914919306022 (2019).","DOI":"10.1016\/j.amjcard.2019.05.035"},{"key":"45656_CR24","unstructured":"Blom DJ, Santos RD, Daclin V, Mercier F, Ruiz AJ, Danchin N. The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International Cholesterol management Practice Study."},{"issue":"5","key":"45656_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/03007995.2021.1895736","volume":"37","author":"K Iglay","year":"2021","unstructured":"Iglay, K. et al. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis. Curr. Med. Res. Opin. 37(5), 743\u201351. https:\/\/doi.org\/10.1080\/03007995.2021.1895736 (2021).","journal-title":"Curr. Med. Res. Opin."},{"key":"45656_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/J.JDIACOMP.2015.02.014","volume":"29","author":"L Ji","year":"2015","unstructured":"Ji, L. et al. Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomes. J. Diabetes Complic. 29, 488\u2013496. https:\/\/doi.org\/10.1016\/J.JDIACOMP.2015.02.014 (2015).","journal-title":"J. Diabetes Complic."},{"key":"45656_CR27","doi-asserted-by":"crossref","unstructured":"Bays HE, Kirkpatrick C, Maki KC, Toth PP, Morgan RT, Tondt J, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid association 2024. Obesity Pillars 10:100108. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S266736812400010X (2024).","DOI":"10.1016\/j.obpill.2024.100108"},{"issue":"1","key":"45656_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12933-025-02648-1","volume":"24","author":"A Rossi","year":"2025","unstructured":"Rossi, A. et al. Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian associations of medical diabetologists database. Cardiovas. Diabetol. 24(1), 94. https:\/\/doi.org\/10.1186\/s12933-025-02648-1 (2025).","journal-title":"Cardiovas. Diabetol."},{"issue":"11","key":"45656_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","volume":"28","author":"KK Ray","year":"2021","unstructured":"Ray, K. K. et al. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur. J. Prev. Cardiol. 28(11), 1279\u201389. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa047 (2021).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"45656_CR30","doi-asserted-by":"crossref","unstructured":"Nanna MG, Kolkailah AA, Page C, Peterson ED, Navar AM. Use of sodium-glucose cotransporter 2 inhibitors and glucagonlike peptide-1 receptor agonists in patients with diabetes and cardiovascular disease in community practice. JAMA Cardiol 8(1):89\u201395. https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2797900 (2023).","DOI":"10.1001\/jamacardio.2022.3839"},{"key":"45656_CR31","doi-asserted-by":"crossref","unstructured":"Sridhar VS, Dubrofsky L, Boulet J, Cherney DZ. Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection. Jornal Brasileiro de Nefrologia 42(4):467 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7860654\/ (2020).","DOI":"10.1590\/2175-8239-jbn-2020-0100"},{"issue":"7","key":"45656_CR32","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1007\/s12325-025-03230-7","volume":"42","author":"E Ortega","year":"2025","unstructured":"Ortega, E., Redondo-Ant\u00f3n, J., D\u00edaz-Cerezo, S., Rubio-de Santos, M. & Romera, I. Glycaemic and weight control in people aged 65 or younger newly diagnosed with type 2 diabetes in spain: insights from the PRIORITY-T2D study. Adv. Therapy 42(7), 3354\u201368. https:\/\/doi.org\/10.1007\/s12325-025-03230-7 (2025).","journal-title":"Adv. Therapy"},{"key":"45656_CR33","doi-asserted-by":"crossref","unstructured":"Dixon DL, Salgado TM, Robinson A, Carbone S, Wagner TD, Hyder H, et al. Prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes at cardiology, endocrinology, and primary care visits. Mayo Clin Proc 100(4):647\u201356. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0025619624004634 (2025).","DOI":"10.1016\/j.mayocp.2024.08.026"},{"key":"45656_CR34","doi-asserted-by":"crossref","unstructured":"Maranta F, Cianfanelli L, Rizzo M, Cianflone D. Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action. Int J Cardiol 329:205\u20137 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167527320343229?casa_token=PMKUKWfvS4sAAAAA:Djrtt3faEGSDIu6FjmHX0_LhSVHtegClrilcIcpcu1zu6SyrzMeGBMc3Id73AjjlqiNcVZFnMkE7 (2021)","DOI":"10.1016\/j.ijcard.2020.12.074"},{"issue":"9","key":"45656_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"JJ Joseph","year":"2022","unstructured":"Joseph, J. J. et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the american heart association. Circulation 145(9), 722\u201359. https:\/\/doi.org\/10.1161\/CIR.0000000000001040 (2022).","journal-title":"Circulation"},{"key":"45656_CR36","doi-asserted-by":"crossref","unstructured":"Tu Q, Lin S, Hyun K, Hafiz N, Manandi D, Koh AS, et al. The effects of multidisciplinary collaborative care on cardiovascular risk factors among patients with diabetes in primary care settings: a systematic review and meta-analysis. Prim Care Diabetes 18(4):381\u201392 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1751991824001116 (2024).","DOI":"10.1016\/j.pcd.2024.05.003"},{"issue":"16","key":"45656_CR37","doi-asserted-by":"publisher","first-page":"1450928","DOI":"10.3389\/fendo.2025.1450928","volume":"6","author":"SB Dagnew","year":"2025","unstructured":"Dagnew, S. B., Wondm, S. A., Yitayew Tarekegn, G., Kassaw, A. T. & Moges, T. A. Clinical inertia and treatment intensification among patients with type ii diabetes mellitus at Debre Tabor comprehensive specialized hospital, Ethiopia: an institutional-based cross-sectional study. Front. Endocrinol. (Lausanne). 6(16), 1450928 (2025).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"45656_CR38","doi-asserted-by":"crossref","unstructured":"Wrzal PK, Bunko A, Myageri V, Kukaswadia A, Neish CS, Ivers NM. Strategies to overcome therapeutic inertia in type 2 diabetes mellitus: a scoping review. Can J Diabetes 45(3):273-281.e13 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1499267120303531 (2021).","DOI":"10.1016\/j.jcjd.2020.08.109"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45656-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:23:58Z","timestamp":1779056638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45656-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45656-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\n                      Ethics\n                      The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of \u201cPius Brinzeu\u201d Emergency Hospital, Timisoara, Romania (approval number 418\/ 01.11.2023). Informed consent was obtained from all subjects involved in the study and is included in patients\u2019 hospital records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15230"}}